As of November 2024, NeoPharm has a market cap of $139.11M. This makes NeoPharm the world's 19451th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $161.70M | 3.87% |
2023 | $155.67M | 34.99% |
2022 | $115.33M | -22.63% |
2021 | $149.05M | -50.00% |
2018 | $298.10M | 4.98% |
2017 | $283.95M | 80.65% |
2016 | $157.18M | -24.78% |
2015 | $208.97M | 141.81% |
2014 | $86.42M | 187.29% |
2013 | $30.08M | -17.57% |
2012 | $36.49M | - |